Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
0.6458
+0.0235 (3.78%)
At close: Jun 26, 2026, 4:00 PM EDT
0.6384
-0.0074 (-1.15%)
After-hours: Jun 26, 2026, 7:42 PM EDT
Adagio Medical Holdings Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
41
Market Cap
14.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 602.00K | 302.00K | 100.67% |
| Dec 31, 2023 | 300.00K | 111.00K | 58.73% |
| Dec 31, 2022 | 189.00K | -81.00K | -30.00% |
| Dec 31, 2021 | 270.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IRIDEX | 52.58M |
| Lifeward | 20.92M |
| Picard Medical | 5.47M |
| IceCure Medical | 3.57M |
| VolitionRx | 2.47M |
| Sintx Technologies | 1.03M |
| Co-Diagnostics | 718.17K |
| Phaos Technology Holdings (Cayman) Limited | 147.64K |
ADGM News
- 11 days ago - Adagio Medical Holdings Transcript: AGM 2026 - Transcripts
- 25 days ago - Adagio Medical initiated with a Buy at Lucid Capital - TheFly
- 5 weeks ago - Adagio Medical submits PMA application to FDA for vCLAS Ventricular Ablation - TheFly
- 5 weeks ago - Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia - Business Wire
- 6 weeks ago - Adagio Medical Holdings Transcript: BofA Securities 2026 Health Care Conference - Transcripts
- 6 weeks ago - Adagio Medical Holdings Slides: FY 2026 - Filings
- 6 weeks ago - Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress - Business Wire
- 6 weeks ago - Adagio Medical Holdings Quarterly report: Q1 2026 - Filings